Combined Randomised and Observational Study of Type B Ankle Fracture Treatment
- Conditions
- Ankle Fractures
- Interventions
- Procedure: Non OperativeProcedure: Open reduction internal fixation of the ankle
- Registration Number
- NCT01134094
- Lead Sponsor
- The University of New South Wales
- Brief Summary
This study will determine whether operative management confers improved short and long-term outcomes for patients with isolated AO type 44-B1 distal fibula fractures when compared with non-operative management.
- Detailed Description
Background:
Ankle fractures are common. Recent clinical studies have shown that there is an increasing incidence of ankle fractures. Treatments vary and there is no clear consensus of the ideal approach to type 44-B1 distal fibular fractures. They range from open reduction and internal fixation to restore anatomical alignment to wearing below-knee walking plaster for an average of six weeks.
The argument for surgical fixation is that it addresses minor displacement and possible future displacement therefore potentially preventing future arthritis. On the other hand, there are numerous complications associated with surgery.
The argument for non-operative treatment is that non-union is not a common complication. Therefore surgery can be avoided in the majority of cases avoiding the clinical risks associated with surgery.
Aim:
Primary aim: To compare, ankle function and quality of life in the 12 months following an isolated AO type 44-B1 distal fibula fracture minimal talar shift, between patients treated operatively and non-operatively.
Secondary aims:
1. To compare the recovery of ankle function and quality of life between the two study groups from 3 months to 1 year post ankle fracture
2. To compare complications between the two groups.
3. To conduct a health economic analysis between the two groups as indicated
Research Design: Combined Randomised and Observational Study
Methods:
Recruitment:
All consecutive patients who present to a recruiting hospital with a distal fibular fracture during the study period will be screened for eligibility. In most hospitals, all surgeons on the on-call roster will participate in the study. Consenting patients of the surgeons who have agreed to participate in the randomised arm of the trial will be invited to have their treatment randomised. Patients of surgeons involved in the observational component of the study will be invited to be included in the observational arm together with the patients who decline to be randomised, but consent to follow-up
Written, informed consent will be obtained.
Eligible patients of surgeons participating in the randomised arm will have the option of having their treatment randomised. If consent is given, the surgeon will call a central number for patient allocation that is available 24 hours per day, 7 days per week. The randomisation schedule will be prepared and administered by an external party not otherwise involved in the study. If the patient declines randomisation, treatment will be determined after surgeon-patient discussion. Eligible patients of surgeons involved in the observational arm will also have their treatment provided (operative or non-operative) as per usual surgeon practice.
Typical demographic, anthropometric and surgical details (where appropriate) will be recorded for contextual reference.
Surgical intervention:
The surgical technique for each patient managed operatively, in both the observational and randomised arms of the study, will include fixation using a plate and screws. Any adverse intra-operative or post-operative event will be recorded. This includes but is not limited to death, infection, VTE and neurovascular injury. Post-operatively, all patients will be non weight bearing and placed in a below-knee plaster cast or walking boot. Discharge from hospital will be determined by the patient's ability to walk 25 m unaided by standby assistance as determined by a physiotherapist. The treating surgeon will review the patient after 10-14 days for assessment of the wound, removal of sutures and change of cast to a fibreglass cast or walking boot (cam walker). The patient will then be allowed to WBAT (weight bearing as tolerated) for a further 4 weeks. This protocol represents usual post-operative practice for this injury, as determined through meetings with the Australian Orthopaedic Trauma Society.
Non-Operative management:
Patients who are treated non-operatively will be treated with a walking boot and allowed WBAT. Discharge from hospital will be determined as for the surgical arm. All patients will be reviewed between 7 and 14 days post injury with repeat radiographs by the treating surgeon. This represents usual non-operative treatment for this injury.
Other management decisions such as need for antibiotics, VTE prophylaxis or anaesthetic type will be as per usual care for that institution and recorded by the research team. Referral for further physiotherapy post removal of cast or boot (either study arm) will be based on the presence of overt ankle stiffness affecting gait. The use of physiotherapy (type and duration) will be noted. Specific prescription of the type of physiotherapy is not possible as patients will be free to access public and private services. Study participants will record all hospitalisations and visits to any health professional. They will be required to report the main reason for such health service occasions during the first year of follow-up period.
Outcomes will be collected and results will be reported in peer-reviewed journals after appropriate statistical analysis.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 160
- Arbeitsgemeinschaft für Osteosynthesefragen (AO) type 44-B1 fibula fracture
- Patients aged between 18 and 65 inclusive.
- No talar shift - Medial clear space less than 2mm compared with the superior clear space on anterior-posterior (AP) view of the ankle.
- Closed injury
- No concurrent fractures/dislocations
- Mobilising unaided/independently pre-injury
- Willingness to be followed up for 12 months
- Able to provide informed written consent
- Medically fit for general anaesthesia/surgery
- Dislocation on presentation
- Skeletally immature patients
- Previous trauma or surgery to the affected ankle
- Pregnancy
- Other injuries that impede mobilisation e.g. stroke, neurovascular deficit at presentation
- Non-English speaking
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Non-Operative Non Operative Patients who are treated non-operatively will be treated with a walking boot and allowed WBAT. Discharge from hospital will be determined by the patient walking 25m unaided by standby assistance. All patients will be reviewed between 7 and 14 days post injury with repeat x-rays by the treating surgeon. Operative Open reduction internal fixation of the ankle The specific procedure for each patient managed operatively, both in the observational study and the RCT, will be determined by the operating surgeon. Any adverse intra-operative or post-operative event will be recorded. This includes but is not limited to death, infection and neurovascular injury. Post operatively, all patients will be NWB (non weight bearing) and placed in a POP (plaster of paris) below knee cast or walking boot. Discharge from hospital will be determined by the patient walking 25m unaided by standby assistance. The treating surgeon will review the patients after 10-14 days for a wound review, removal of sutures and change of cast to a fibreglass cast or walking boot (cam walker). The patient will be WBAT (weight bearing as tolerated) for a further 4 weeks.
- Primary Outcome Measures
Name Time Method PCS of Short Form (SF)-12v2 12 months SF-12 version 2 Health Survey
American Academy of Orthopaedic Surgeons Foot and Ankle Questionnaire 12 months American Academy of Orthopaedic Surgeons Foot and Ankle Outcomes Questionnaire
- Secondary Outcome Measures
Name Time Method MCS of Short Form (SF)-12v2 3, 6 and 12 months Short Form (SF)-12v2
PCS Short Form (SF)-12v2 3 and 6 months Short Form (SF)-12v2
Complications 6 weeks, 3, 6 and 12 months Late surgery Infection Neurovascular complication Mortality
American Academy of Orthopaedic Surgeons (AAOS) Foot and Ankle Questionnaire 3 and 6 months American Academy of Orthopaedic Surgeons (AAOS) Foot and Ankle Questionnaire
Trial Locations
- Locations (21)
Royal Brisbane and Women's Hospital
🇦🇺Brisbane, New South Wales, Australia
Sutherland Hospital
🇦🇺Caringbah, New South Wales, Australia
St. George Hospital
🇦🇺Kogarah, New South Wales, Australia
The Alfred Hospital
🇦🇺Melbourne, New South Wales, Australia
Prince of Wales Hospital
🇦🇺Randwick, New South Wales, Australia
The Royal Melbourne Hospital
🇦🇺Parkville, New South Wales, Australia
Wollongong Hospital
🇦🇺Wollongong, New South Wales, Australia
Cairns Base Hospital
🇦🇺Cairns, Queensland, Australia
Mackay Base Hospital
🇦🇺Mackay, Queensland, Australia
Nambour Hospital
🇦🇺Nambour, Queensland, Australia
Flinders Medical Centre
🇦🇺Bedford Park, South Australia, Australia
Lyell McEwin Hospital
🇦🇺Elizabeth Vale, South Australia, Australia
Canberra Hospital
🇦🇺Garran, Australian Capital Territory, Australia
Princess Alexandra Hospital
🇦🇺Woolloongabba, Queensland, Australia
Sir Charles Gairdner Hospital
🇦🇺Perth, Western Australia, Australia
Campbelltown Hospital
🇦🇺Campbelltown, New South Wales, Australia
Royal Prince Alfred
🇦🇺Camperdown, New South Wales, Australia
Royal Adelaide Hospital
🇦🇺Adelaide, South Australia, Australia
Liverpool Hospital
🇦🇺Liverpool, New South Wales, Australia
John Hunter Hospital
🇦🇺New Lambton, New South Wales, Australia
Westmead Hospital
🇦🇺Westmead, New South Wales, Australia